CD8A and non-small cell lung carcinoma: One case report of a patient with non-small cell lung cancer (NSCLC) who experienced a complete response to RT and CTLA4 blockade demonstrated a rapid in vivo expansion of CD8+ T-cells that recognized a neoantigen encoded in a gene upregulated by RT (8).